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contralateral breast, humeral head, spinal cord, skin and ipsolateral lung). We also compared the uniformity and the van’t Riet
conformation indexes.
Results. Comparing the techniques by pairs, the results indicated that the segmented technique is superior to classical for breast-
only cases, specially for left breasts due to heart sparing. No signiﬁcances were observed for chest wall and lymph nodes cases
except better avoidance of OAR dose for segmented. IMRT is statistically better than classical for all kind of cases, though it carries
more low doses for OAR. Finally, IMRT is superior to segmented for breast-only and lymph nodes cases, but they are statistically
equiparable for chest walls. Again IMRT supposes more low doses for OAR.
Conclusion. This pilot study has given us a better understanding of the capabilities of every technique and helped us decide the
most appropriate dosimetric planning protocol for every breast case.
http://dx.doi.org/10.1016/j.rpor.2013.03.082
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Introduction. The management of information is crucial to optimize the operation of Breast Functional Units and ensure the
success of personalized medicine.
Objective. To have an advanced tool that allows the “integration of all the information generated by the services” involved in Breast
Functional Units, including the service of Radiation Oncology. Providing professionals a support system for clinical decision
helping them to decide what to do with the patient, during diagnosis, prognosis and treatment of the disease and enabling
personalized healthcare.
Material and methods. Task groups with all specialties, analyzing their structure, protocols, records and workﬂow between profes-
sionals, obtaining a collection of requirements to implement in the new information system. Prototypes are developed to validate
the interfaces, functionality and usability of the ﬁnal product, ensuring alignment with existing coding standards, procedures
and health information technology.
Results. Platform “patient-oriented” to improve the effectiveness of exchange of information and knowledge between profession-
als, offering a centralized view of the disease in real time and support tools for decision based in semantics. The obtained tool
is aligned with the following elements: • Electronic medical records; • Conﬁdentiality; • Collaborative work between different
services; • Support for professionals (ontologies to propose and guide in clinical decision); • Improving the quality of information
handled and the time spent in the query.
Conclusions. The new platform will provide to the professionals of the services involved in the diagnosis and treatment of breast
cancer, a new way of working, based on information technologies. Semantic ontologies have been implemented oriented to the
healthcare environment in the areas of diagnosis, individualized treatment and clinical decision support.
http://dx.doi.org/10.1016/j.rpor.2013.03.083
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Introduction. Breast-conserving therapy is the standard of care for early breast cancer. The conventional technique of radiotherapy
includes irradiation to the whole breast followed by a tumour bed boost. Reducing the overall treatment time could decrease the
inconvenience to the patient.
Objective. To evaluate toxicity, cosmetic result and survival in patients with breast cancer treated with radiotherapy and con-
comitant boost to the tumour bed in our centre between 2007 and 2009.
Methods. Descriptive and retrospective analysis. All patientswere treatedwith 3D-conformal external radiotherapy. They received
50Gy to the whole breast, 2Gy per fraction, 5 fractions per week. Toxicities were scored according to the common toxicity criteria
version 4.
Results. 196 patients underwent radiotherapy with concomitant boost between September of 2008 and April of 2010. We collected
data from 162 patients. Median follow-up was 30 months. Median age 52 years, the majority of cases were: postmenopausal
women (54%), ductal histology (75.3%), hormone receptor-positive (81%), HER-2-negative (79%), stage I-IIA (72%). Patients under-
went tumorectomy in 91% and axillar surgery in 73.5%. In 39 patients boost daily doses was 0.53Gy and 0.34Gy in 123 women.
The most common acute toxicity was radiodermitis grade 1 (49.4%) and ﬁbrosis grade 1–2 was the most frequent late toxicity.
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There was no toxicity grade 4. The cosmetic outcome was excellent in 56% of patients and good in 22%. At the end of the study,
locorregional relapse occurred in 6 patients, 94.4% were alive without disease, 5% were alive with disease and 0.6% died from
tumor.
Conclusion. Concomitant boost is feasible and safe for patients with breast cancer underwent to conservative treatment.
http://dx.doi.org/10.1016/j.rpor.2013.03.084
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Bilateral breast cancer is rare but increasing because of better diagnosis. Treatment with radiotherapy is difﬁcult because match-
line overlap must be avoided and Organ at risk (OAR) spared. This study evaluated dose distribution, homogeneity and dose to
OAR in women with advanced bilateral breast carcinoma undergoing radiotherapy to breast and regional nodal using standard
3D external beam radiotherapy (3DEBRT) versus IMRT after breast conserving surgery and chemotherapy. Volumes were delin-
eated on 6 patients. The 3DEBRT technique involved bilateral tangential ﬁelds for breast and two oblique, one anterior and one
posterior, to the supraclavicular fossa. IMRT technique involved several multiﬁeld coplanar inverse planning. The prescription
dose was 50Gy in 25 fractions. Dose-volume histograms, dose homogeneity and dose to OAR were evaluated. IMRT results were
superior to 3D-EBRT with signiﬁcant improvements in achieving lower mean lungs dose and reducing the volume of heart in the
medium-high dose region V30. PTV coverages were always equal to or greater in IMRT than 3D-EBRT technique. IMRT is ideal
for treating complex treatment volumes in bilateral breast cancer, improving dose homogeneity and coverage. Moreover reduces
normal tissue complications through organ at risk sparing.
http://dx.doi.org/10.1016/j.rpor.2013.03.085
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Introduction. Dosimetric studies have established intensity-modulated radiotherapy (IMRT) as superior to 3D-CRT in terms of
target coverage, conformity, and sparing of normal tissues and equivalent for survival outcomes. However, concern has been
raised regarding its hypothetical higher integral dose to normal tissues and the potential carcinogenic risk. We compare three
different radiotherapy modalities for real clinical situations.
Material and methods. 10 patients with early breast cancer treated with conservative surgery were referred to receive radiotherapy
to our clinic. After individualized evaluation in a clinical meeting, all patients were proposed to undergo IMRT treatment (step
and shoot). Every patient was re-planned with 3D-CRT and Volumetric Modulated Arc Therapy (VMAT).
Objectives. Compare the dosimetric results by 3D-CRT, IMRT step and shoot and VMAT.
Results. We analyzed dosimetric results created by the three plans. The data provided by Dose-volume histogram analysis showed
each patient dose constraints for organ at risk and PTV coverage.
Conclusions. IMRT techniques show to be superior to 3D-CRT not only in terms of coverage and homogeneity, but also decreasing
integral dose according to our dosimetric data.
http://dx.doi.org/10.1016/j.rpor.2013.03.086
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Background. Breast cancers are more frequently diagnosed at an early stage and have improved long term outcomes. Late normal
tissue complications induced by adjuvant radiotherapy must be avoided. New breast radiotherapy techniques have been devel-
oped. Aim of study was to compare dosimetric parameters of the planning target volume (PTV), organs at risk (OARs) between
conformal radiation therapy (3DCRT) and intensity-modulated radiation therapy (IMRT) after breast-conserving surgery.
Methods. 20 patients were studied who had early stage left breast cancer, received adjuvant radiotherapy after conservative
surgery, CT-scan was used, 10 patients treated by 3D-CRT and 10 by IMRT, dose was 50Gy in 25 sessions. Plans were compared
